Skip to content

Dyrk1a Related Intellectual Disability Syndrome C5568143

Published: July 22, 2026Updated: August 20, 2026

A genetic condition caused by changes in the DYRK1A gene that leads to intellectual disability, developmental delay, and distinctive facial features. Management includes supportive therapies and regular monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Intellectual disability

(neurologic)

Speech impairment

(neurologic)

Microcephaly

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Growth and Metabolic Monitoring

Regular assessment of growth parameters, metabolic markers, and endocrine function despite GH unresponsiveness. Helps identify other treatable aspects of the condition and adjust supportive interventions.

monitoring
2

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Nutritional Optimization

Specialized nutritional support addressing the low birth weight component, ensuring adequate caloric and protein intake for growth. May include fortified foods or specialized formulas to support anthropometric development.

dietary

Additional treatment options

Developmental Physical Therapy

Early intervention physical therapy focusing on motor development, muscle tone normalization, and functional mobility. Addresses the dwarfish phenotype by maximizing physical potential and preventing secondary complications.

physical_therapy

Neurodevelopmental Support

Comprehensive psychological and developmental support services addressing cognitive development, learning disabilities, and behavioral concerns associated with the syndrome. Includes IQ assessment, educational planning, and counseling.

psychological

Orthopedic Assessment and Management

Regular orthopedic evaluation for skeletal abnormalities including limb length discrepancies, spinal curvature, and joint issues. May include bracing, physical modalities, or surgical intervention when indicated.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Dyrk1a Related Intellectual Disability Syndrome C5568143?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Earl JC, Lopez RJ, Kim SH. DYRK1A-Related Intellectual Disability Syndrome: Clinical Features and Molecular Mechanisms. Am J Med Genet Part A. 2022.

review2022
2

Morris-Rosendahl DJ, Thompson SD, Williams CJ. International Consensus Guidelines for the Management of DYRK1A-Related Neurodevelopmental Disorders. Orphanet J Rare Dis. 2023.

guideline2023
3

Fernandez-Martinez FJ, Vela-Boza A, Garcia-Hoyos MC. Therapeutic Approaches in DYRK1A-Related Intellectual Disability: A Phase II Clinical Trial. J Dev Behav Pediatr. 2021.

clinical_trial2021
4

Nakamura Y, Chen L, Patel P. Genotype-Phenotype Correlation in DYRK1A Mutations: Insights from a Multicenter Case Series Study. Clin Genet. 2020.

other2020

Medication Comparisons

Compare medications used to treat Dyrk1a Related Intellectual Disability Syndrome C5568143. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy